Patents by Inventor Matthias Vaska

Matthias Vaska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030079753
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Application
    Filed: August 30, 2002
    Publication date: May 1, 2003
    Applicant: EPICOR, INC.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20030078571
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: September 10, 2002
    Publication date: April 24, 2003
    Applicant: Epicor, Inc.
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Scott C. Anderson, Gerard Champsaur, John E. Crowe, Stephen A. Morse, Gary Henry Miller
  • Publication number: 20030073992
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: September 10, 2002
    Publication date: April 17, 2003
    Applicant: Epicor, Inc.
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Scott C. Anderson, Gerard Champsaur, John E. Crowe, Stephen A. Morse, Gary Henry Miller
  • Publication number: 20030069577
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Application
    Filed: August 30, 2002
    Publication date: April 10, 2003
    Applicant: EPICOR, INC.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20030069574
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: December 5, 2001
    Publication date: April 10, 2003
    Applicant: Epicor, Inc.
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Publication number: 20030029462
    Abstract: The invention provides surgical systems and methods for ablating heart tissue within the interior and/or exterior of the heart. A plurality of probes is provided with each probe configured for introduction into the chest for engaging the heart. Each probe includes an elongated shaft having an elongated ablating surface of a predetermined shape. The elongated shaft and the elongated ablating surface of each probe are configured to ablate a portion of the heart. A sealing device affixed to the heart tissue forms a hemostatic seal between the probe and the penetration in the heart to inhibit blood loss therethrough.
    Type: Application
    Filed: June 14, 2002
    Publication date: February 13, 2003
    Applicant: Epicor, Inc.
    Inventors: James L. Cox, Stephen W. Boyd, Hanson S. Gifford, Matthias Vaska, Daniel D. Merrick
  • Publication number: 20030024537
    Abstract: The invention provides surgical systems and methods for ablating heart tissue within the interior and/or exterior of the heart. A plurality of probes is provided with each probe configured for introduction into the chest for engaging the heart. Each probe includes an elongated shaft having an elongated ablating surface of a predetermined shape. The elongated shaft and the elongated ablating surface of each probe are configured to ablate a portion of the heart. A sealing device affixed to the heart tissue forms a hemostatic seal between the probe and the penetration in the heart to inhibit blood loss therethrough.
    Type: Application
    Filed: June 12, 2002
    Publication date: February 6, 2003
    Applicant: Epicor, Inc.
    Inventors: James L. Cox, Stephen W. Boyd, Hanson S. Gifford, Matthias Vaska, Daniel D. Merrick
  • Publication number: 20030028187
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Application
    Filed: June 12, 2002
    Publication date: February 6, 2003
    Applicant: Epicor, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6494211
    Abstract: Surgical methods and instruments are disclosed for performing port-access or closed-chest coronary artery bypass (CABG) surgery in multivessel coronary artery disease. In contrast to standard open-chest CABG surgery, which requires a median stemotomy or other gross thoracotomy to expose the patient's heart, port-access CABG surgery is performed through small incisions or access ports made through the intercostal spaces between the patient's ribs, resulting in greatly reduced pain and morbidity to the patient. In situ arterial bypass grafts, such as the internal mammary arteries and/or the right gastroepiploic artery, are prepared for grafting by thoracoscopic or laparoscopic takedown techniques. Free grafts, such as a saphenous vein graft or a free arterial graft, can be used to augment the in situ arterial grafts. The graft vessels are anastomosed to the coronary arteries under direct visualization through a cardioscopic microscope inserted through an intercostal access port.
    Type: Grant
    Filed: January 19, 2000
    Date of Patent: December 17, 2002
    Assignee: Hearport, Inc.
    Inventors: Stephen W. Boyd, Alan R. Rapacki, Matthias Vaska, Brian S. Donlon, William S. Peters
  • Patent number: 6484727
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 26, 2002
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Banjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20020173784
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: February 15, 2002
    Publication date: November 21, 2002
    Applicant: Epicor, Inc.
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Scott C. Anderson, Gerard Champsaur, John E. Crowe, Stephen A. Morse, Gary Henry Miller
  • Patent number: 6478029
    Abstract: Surgical methods and instruments are disclosed for performing port-access or closed-chest coronary artery bypass (CABG) surgery in multivessel coronary artery disease. In contrast to standard open-chest CABG surgery, which requires a median sternotomy or other gross thoracotomy to expose the patient's heart, post-access CABG surgery is performed through small incisions or access ports made through the intercostal spaces between the patient's ribs, resulting in greatly reduced pain and morbidity to the patient. In situ arterial bypass grafts, such as the internal mammary arteries and/or the right gastroepiploic artery, are prepared for grafting by thoracoscopic or laparoscopic takedown techniques. Free grafts, such as a saphenous vein graft or a free arterial graft, can be used to augment the in situ arterial grafts. The graft vessels are anastomosed to the coronary arteries under direct visualization through a cardioscopic microscope inserted through an intercostal access port.
    Type: Grant
    Filed: August 5, 2000
    Date of Patent: November 12, 2002
    Assignee: Hearport, Inc.
    Inventors: Stephen W. Boyd, Alan R. Rapacki, Matthias Vaska, Brian S. Donlon, William S. Peters
  • Patent number: 6474340
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 5, 2002
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20020128639
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Application
    Filed: December 21, 2001
    Publication date: September 12, 2002
    Applicant: EPICOR, INC., a Delaware Corporation
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad
  • Publication number: 20020092533
    Abstract: Surgical methods and instruments are disclosed for performing port-access or closed-chest coronary artery bypass (CABG) surgery in multivessel coronary artery disease. In contrast to standard open-chest CABG surgery, which requires a median sternotomy or other gross thoracotomy to expose the patient's heart, port-access CABG surgery is performed through small incisions or access ports made through the intercostal spaces between the patient's ribs, resulting in greatly reduced pain and morbidity to the patient. In situ arterial bypass grafts, such as the internal mammary arteries and/or the right gastroepiploic artery, are prepared for grafting by thoracoscopic or laparoscopic takedown techniques. Free grafts, such as a saphenous vein graft or a free arterial graft, can be used to augment the in situ arterial grafts. The graft vessels are anastomosed to the coronary arteries under direct visualization through a cardioscopic microscope inserted through an intercostal access port.
    Type: Application
    Filed: October 19, 2001
    Publication date: July 18, 2002
    Inventors: Stephen W. Boyd, Alan R. Rapacki, Matthias Vaska, Brian S. Donlon, William S. Peters
  • Publication number: 20020087183
    Abstract: Surgical methods and instruments are disclosed for performing port-access or closed-chest coronary artery bypass (CABG) surgery in multivessel coronary artery disease. In contrast to standard open-chest CABG surgery, which requires a median sternotomy or other gross thoracotomy to expose the patient's heart, port-access CABG surgery is performed through small incisions or access ports made through the intercostal spaces between the patient's ribs, resulting in greatly reduced pain and morbidity to the patient. In situ arterial bypass grafts, such as the internal mammary arteries and/or the right gastroepiploic artery, are prepared for grafting by thoracoscopic or laparoscopic takedown techniques. Free grafts, such as a saphenous vein graft or a free arterial graft, can be used to augment the in situ arterial grafts. The graft vessels are anastomosed to the coronary arteries under direct visualization through a cardioscopic microscope inserted through an intercostal access port.
    Type: Application
    Filed: October 19, 2001
    Publication date: July 4, 2002
    Inventors: Stephen W. Boyd, Alan R. Rapacki, Matthias Vaska, Brian S. Donlon, William S. Peters, John H. Stevens
  • Publication number: 20020087157
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: December 5, 2001
    Publication date: July 4, 2002
    Applicant: Epicor, Inc.
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Publication number: 20020074004
    Abstract: Surgical methods and instruments are disclosed for performing port-access or closed-chest coronary artery bypass (CABG) surgery in multivessel coronary artery disease. In contrast to standard open-chest CABG surgery, which requires a median sternotomy or other gross thoracotomy to expose the patient's heart, port-access CABG surgery is performed through small incisions or access ports made through the intercostal spaces between the patient's ribs, resulting in greatly reduced pain and morbidity to the patient. In situ arterial bypass grafts, such as the internal mammary arteries and/or the right gastroepiploic artery, are prepared for grafting by thoracoscopic or laparoscopic takedown techniques. Free grafts, such as a saphenous vein graft or a free arterial graft, can be used to augment the in situ arterial grafts. The graft vessels are anastomosed to the coronary arteries under direct visualization through a cardioscopic microscope inserted through an intercostal access port.
    Type: Application
    Filed: October 19, 2001
    Publication date: June 20, 2002
    Inventors: Stephen W. Boyd, Alan R. Rapacki, Matthias Vaska, Brian S. Donlon, William S. Peters, John H. Stevens
  • Publication number: 20020069884
    Abstract: Surgical methods and instruments are disclosed for performing port-access or closed-chest coronary artery bypass (CABG) surgery in multivessel coronary artery disease. In contrast to standard open-chest CABG surgery, which requires a median sternotomy or other gross thoracotomy to expose the patient's heart, port-access CABG surgery is performed through small incisions or access ports made through the intercostal spaces between the patient's ribs, resulting in greatly reduced pain and morbidity to the patient. In situ arterial bypass grafts, such as the internal mammary arteries and/or the right gastroepiploic artery, are prepared for grafting by thoracoscopic or laparoscopic takedown techniques. Free grafts, such as a saphenous vein graft or a free arterial graft, can be used to augment the in situ arterial grafts. The graft vessels are anastomosed to the coronary arteries under direct visualization through a cardioscopic microscope inserted through an intercostal access port.
    Type: Application
    Filed: October 19, 2001
    Publication date: June 13, 2002
    Inventors: Stephen W. Boyd, Alan R. Rapacki, Matthias Vaska, Brian S. Donlon, William S. Peters
  • Publication number: 20020072741
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: June 19, 2001
    Publication date: June 13, 2002
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe